SIMILAR PATTERNS OF AMINO ACIDS FOR 4P65_C_IPHC101

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1a27 17-BETA-HYDROXYSTERO
ID-DEHYDROGENASE


(Homo sapiens)
PF00106
(adh_short)
5 CYH A 166
LEU A 165
ALA A 161
VAL A 139
LEU A 182
None
0.97A 4p65C-1a27A:
undetectable
4p65D-1a27A:
undetectable
4p65J-1a27A:
undetectable
4p65L-1a27A:
undetectable
4p65C-1a27A:
5.42
4p65D-1a27A:
7.17
4p65J-1a27A:
7.17
4p65L-1a27A:
7.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1f6f PLACENTAL LACTOGEN

(Ovis aries)
PF00103
(Hormone_1)
5 LEU A 172
HIS A  98
LEU A  97
ALA A 100
LEU A 157
None
1.03A 4p65C-1f6fA:
undetectable
4p65D-1f6fA:
undetectable
4p65J-1f6fA:
undetectable
4p65L-1f6fA:
undetectable
4p65C-1f6fA:
10.42
4p65D-1f6fA:
12.36
4p65J-1f6fA:
12.36
4p65L-1f6fA:
12.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1fdw 17-BETA-HYDROXYSTERO
ID DEHYDROGENASE


(Homo sapiens)
PF00106
(adh_short)
5 CYH A 166
LEU A 165
ALA A 161
VAL A 139
LEU A 182
None
0.97A 4p65C-1fdwA:
undetectable
4p65D-1fdwA:
undetectable
4p65J-1fdwA:
undetectable
4p65L-1fdwA:
undetectable
4p65C-1fdwA:
5.66
4p65D-1fdwA:
6.77
4p65J-1fdwA:
6.77
4p65L-1fdwA:
6.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1gzk RAC-BETA
SERINE/THREONINE
PROTEIN KINASE


(Homo sapiens)
PF00069
(Pkinase)
PF00433
(Pkinase_C)
5 CYH A 345
LEU A 381
LEU A 373
ALA A 377
VAL A 246
None
1.04A 4p65C-1gzkA:
undetectable
4p65D-1gzkA:
undetectable
4p65J-1gzkA:
undetectable
4p65L-1gzkA:
undetectable
4p65C-1gzkA:
7.94
4p65D-1gzkA:
10.13
4p65J-1gzkA:
10.13
4p65L-1gzkA:
10.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1i7k UBIQUITIN-CONJUGATIN
G ENZYME E2 H10


(Homo sapiens)
PF00179
(UQ_con)
5 LEU A 132
LEU A  83
ALA A  52
LEU A  42
LEU A  35
None
0.97A 4p65C-1i7kA:
undetectable
4p65D-1i7kA:
undetectable
4p65J-1i7kA:
undetectable
4p65L-1i7kA:
undetectable
4p65C-1i7kA:
8.06
4p65D-1i7kA:
9.47
4p65J-1i7kA:
9.47
4p65L-1i7kA:
9.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1j33 COBT

(Thermus
thermophilus)
PF02277
(DBI_PRT)
5 LEU A 290
LEU A 259
ALA A 258
LEU A 249
HIS A 283
None
1.07A 4p65C-1j33A:
undetectable
4p65D-1j33A:
undetectable
4p65J-1j33A:
undetectable
4p65L-1j33A:
undetectable
4p65C-1j33A:
5.83
4p65D-1j33A:
5.52
4p65J-1j33A:
5.52
4p65L-1j33A:
5.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1jed SULFATE
ADENYLYLTRANSFERASE


(Saccharomyces
cerevisiae)
PF01747
(ATP-sulfurylase)
PF14306
(PUA_2)
5 LEU A 158
LEU A 104
ALA A 113
LEU A  49
LEU A  42
None
1.09A 4p65C-1jedA:
undetectable
4p65D-1jedA:
undetectable
4p65J-1jedA:
undetectable
4p65L-1jedA:
undetectable
4p65C-1jedA:
3.00
4p65D-1jedA:
7.01
4p65J-1jedA:
7.01
4p65L-1jedA:
7.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1knb ADENOVIRUS TYPE 5
FIBER PROTEIN


(Human
mastadenovirus
C)
PF00541
(Adeno_knob)
5 LEU A 413
LEU A 445
ALA A 440
VAL A 530
LEU A 522
None
1.16A 4p65C-1knbA:
undetectable
4p65D-1knbA:
undetectable
4p65J-1knbA:
undetectable
4p65L-1knbA:
undetectable
4p65C-1knbA:
6.70
4p65D-1knbA:
10.22
4p65J-1knbA:
10.22
4p65L-1knbA:
10.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1luf MUSCLE-SPECIFIC
TYROSINE KINASE
RECEPTOR MUSK


(Rattus
norvegicus)
PF07714
(Pkinase_Tyr)
5 LEU A 855
CYH A 698
LEU A 702
ALA A 705
LEU A 791
None
0.99A 4p65C-1lufA:
undetectable
4p65D-1lufA:
undetectable
4p65J-1lufA:
undetectable
4p65L-1lufA:
undetectable
4p65C-1lufA:
4.47
4p65D-1lufA:
6.34
4p65J-1lufA:
6.34
4p65L-1lufA:
6.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1n7j PHENYLETHANOLAMINE
N-METHYLTRANSFERASE


(Homo sapiens)
PF01234
(NNMT_PNMT_TEMT)
5 LEU A 243
LEU A 213
ALA A 275
LEU A 253
VAL A 234
None
1.10A 4p65C-1n7jA:
undetectable
4p65D-1n7jA:
undetectable
4p65J-1n7jA:
undetectable
4p65L-1n7jA:
undetectable
4p65C-1n7jA:
20.75
4p65D-1n7jA:
8.03
4p65J-1n7jA:
8.03
4p65L-1n7jA:
8.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1re5 3-CARBOXY-CIS,CIS-MU
CONATE
CYCLOISOMERASE


(Pseudomonas
putida)
PF00206
(Lyase_1)
PF10397
(ADSL_C)
5 LEU A 173
LEU A 129
LEU A 247
VAL A 239
LEU A 240
None
1.14A 4p65C-1re5A:
undetectable
4p65D-1re5A:
undetectable
4p65J-1re5A:
undetectable
4p65L-1re5A:
undetectable
4p65C-1re5A:
3.99
4p65D-1re5A:
5.12
4p65J-1re5A:
5.12
4p65L-1re5A:
5.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1tqy ACTINORHODIN
POLYKETIDE PUTATIVE
BETA-KETOACYL
SYNTHASE 2


(Streptomyces
coelicolor)
PF00109
(ketoacyl-synt)
PF02801
(Ketoacyl-synt_C)
5 LEU B 165
LEU B 168
ALA B 398
VAL B 343
LEU B 346
None
1.11A 4p65C-1tqyB:
undetectable
4p65D-1tqyB:
undetectable
4p65J-1tqyB:
undetectable
4p65L-1tqyB:
undetectable
4p65C-1tqyB:
5.47
4p65D-1tqyB:
8.84
4p65J-1tqyB:
8.84
4p65L-1tqyB:
8.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ttw SECRETION CHAPERONE

(Yersinia pestis)
PF05932
(CesT)
5 CYH A  81
LEU A  91
LEU A 119
ALA A  54
LEU A  57
None
0.95A 4p65C-1ttwA:
undetectable
4p65D-1ttwA:
undetectable
4p65J-1ttwA:
undetectable
4p65L-1ttwA:
undetectable
4p65C-1ttwA:
9.35
4p65D-1ttwA:
15.05
4p65J-1ttwA:
15.05
4p65L-1ttwA:
15.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1wlj INTERFERON
STIMULATED GENE
20KDA


(Homo sapiens)
PF00929
(RNase_T)
5 CYH A  28
LEU A  25
LEU A  98
ALA A  97
LEU A  91
None
1.14A 4p65C-1wljA:
undetectable
4p65D-1wljA:
undetectable
4p65J-1wljA:
undetectable
4p65L-1wljA:
undetectable
4p65C-1wljA:
7.84
4p65D-1wljA:
11.39
4p65J-1wljA:
11.39
4p65L-1wljA:
11.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1xm9 PLAKOPHILIN 1

(Homo sapiens)
PF00514
(Arm)
5 LEU A 296
LEU A 311
ALA A 308
LEU A 350
LEU A 357
None
1.12A 4p65C-1xm9A:
undetectable
4p65D-1xm9A:
undetectable
4p65J-1xm9A:
undetectable
4p65L-1xm9A:
undetectable
4p65C-1xm9A:
3.86
4p65D-1xm9A:
6.67
4p65J-1xm9A:
6.67
4p65L-1xm9A:
6.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2b8e CATION-TRANSPORTING
ATPASE


(Archaeoglobus
fulgidus)
PF00702
(Hydrolase)
5 LEU A 429
LEU A 655
ALA A 554
LEU A 586
VAL A 421
None
1.12A 4p65C-2b8eA:
undetectable
4p65D-2b8eA:
undetectable
4p65J-2b8eA:
undetectable
4p65L-2b8eA:
undetectable
4p65C-2b8eA:
8.70
4p65D-2b8eA:
8.13
4p65J-2b8eA:
8.13
4p65L-2b8eA:
8.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2b8e CATION-TRANSPORTING
ATPASE


(Archaeoglobus
fulgidus)
PF00702
(Hydrolase)
5 LEU A 655
ALA A 554
LEU A 586
VAL A 421
LEU A 561
None
0.96A 4p65C-2b8eA:
undetectable
4p65D-2b8eA:
undetectable
4p65J-2b8eA:
undetectable
4p65L-2b8eA:
undetectable
4p65C-2b8eA:
8.70
4p65D-2b8eA:
8.13
4p65J-2b8eA:
8.13
4p65L-2b8eA:
8.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2d96 NUCLEAR FACTOR
NF-KAPPA-B P100
SUBUNIT


(Homo sapiens)
PF00531
(Death)
5 LEU A  36
LEU A  77
ALA A  76
LEU A  40
LEU A  70
None
1.03A 4p65C-2d96A:
undetectable
4p65D-2d96A:
undetectable
4p65J-2d96A:
undetectable
4p65L-2d96A:
undetectable
4p65C-2d96A:
9.17
4p65D-2d96A:
15.84
4p65J-2d96A:
15.84
4p65L-2d96A:
15.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2dul N(2),N(2)-DIMETHYLGU
ANOSINE TRNA
METHYLTRANSFERASE


(Pyrococcus
horikoshii)
PF02005
(TRM)
5 LEU A 233
LEU A 151
ALA A 154
VAL A 162
LEU A 137
None
0.87A 4p65C-2dulA:
undetectable
4p65D-2dulA:
undetectable
4p65J-2dulA:
undetectable
4p65L-2dulA:
undetectable
4p65C-2dulA:
4.18
4p65D-2dulA:
6.12
4p65J-2dulA:
6.12
4p65L-2dulA:
6.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2e2c UBIQUITIN
CONJUGATING ENZYME


(Spisula
solidissima)
PF00179
(UQ_con)
5 LEU A 132
LEU A  83
ALA A  52
LEU A  42
LEU A  35
None
1.03A 4p65C-2e2cA:
undetectable
4p65D-2e2cA:
undetectable
4p65J-2e2cA:
undetectable
4p65L-2e2cA:
undetectable
4p65C-2e2cA:
9.68
4p65D-2e2cA:
9.15
4p65J-2e2cA:
9.15
4p65L-2e2cA:
9.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2efj 3,7-DIMETHYLXANTHINE
METHYLTRANSFERASE


(Coffea
canephora)
PF03492
(Methyltransf_7)
5 LEU A  47
CYH A  38
LEU A  42
ALA A  45
LEU A 287
None
1.06A 4p65C-2efjA:
undetectable
4p65D-2efjA:
undetectable
4p65J-2efjA:
undetectable
4p65L-2efjA:
undetectable
4p65C-2efjA:
6.36
4p65D-2efjA:
6.16
4p65J-2efjA:
6.16
4p65L-2efjA:
6.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ffh PROTEIN (FFH)

(Thermus
aquaticus)
PF00448
(SRP54)
PF02881
(SRP54_N)
PF02978
(SRP_SPB)
5 LEU A 257
LEU A   5
LEU A  86
VAL A  78
LEU A 292
None
1.12A 4p65C-2ffhA:
undetectable
4p65D-2ffhA:
undetectable
4p65J-2ffhA:
undetectable
4p65L-2ffhA:
undetectable
4p65C-2ffhA:
4.72
4p65D-2ffhA:
6.36
4p65J-2ffhA:
6.36
4p65L-2ffhA:
6.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2g8l 287AA LONG
HYPOTHETICAL PROTEIN


(Pyrococcus
horikoshii)
PF01937
(DUF89)
5 LEU A 167
CYH A 280
LEU A 259
ALA A 104
LEU A 133
None
1.12A 4p65C-2g8lA:
undetectable
4p65D-2g8lA:
undetectable
4p65J-2g8lA:
undetectable
4p65L-2g8lA:
undetectable
4p65C-2g8lA:
4.42
4p65D-2g8lA:
7.17
4p65J-2g8lA:
7.17
4p65L-2g8lA:
7.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2gnw NON-SYMBIOTIC
HEMOGLOBIN 1


(Oryza sativa)
PF00042
(Globin)
5 LEU A 101
HIS A 152
LEU A 153
ALA A 156
LEU A  88
None
None
HEM  A 166 ( 4.7A)
None
None
1.08A 4p65C-2gnwA:
undetectable
4p65D-2gnwA:
undetectable
4p65J-2gnwA:
undetectable
4p65L-2gnwA:
undetectable
4p65C-2gnwA:
5.45
4p65D-2gnwA:
9.70
4p65J-2gnwA:
9.70
4p65L-2gnwA:
9.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2lxp UBIQUITIN-CONJUGATIN
G ENZYME E2 G2


(Homo sapiens)
PF00179
(UQ_con)
5 LEU A 120
LEU A  58
ALA A  26
LEU A  16
LEU A   9
None
0.95A 4p65C-2lxpA:
undetectable
4p65D-2lxpA:
undetectable
4p65J-2lxpA:
undetectable
4p65L-2lxpA:
undetectable
4p65C-2lxpA:
11.30
4p65D-2lxpA:
12.30
4p65J-2lxpA:
12.30
4p65L-2lxpA:
12.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ng1 SIGNAL SEQUENCE
RECOGNITION PROTEIN
FFH


(Thermus
aquaticus)
PF00448
(SRP54)
PF02881
(SRP54_N)
5 LEU A 257
LEU A   5
LEU A  86
VAL A  78
LEU A 292
None
1.11A 4p65C-2ng1A:
undetectable
4p65D-2ng1A:
undetectable
4p65J-2ng1A:
undetectable
4p65L-2ng1A:
undetectable
4p65C-2ng1A:
5.15
4p65D-2ng1A:
7.64
4p65J-2ng1A:
7.64
4p65L-2ng1A:
7.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2q0f RNA URIDYLYL
TRANSFERASE


(Trypanosoma
brucei)
PF03828
(PAP_assoc)
5 HIS A 320
LEU A 321
ALA A 324
LEU A 329
LEU A 177
None
1.04A 4p65C-2q0fA:
undetectable
4p65D-2q0fA:
undetectable
4p65J-2q0fA:
undetectable
4p65L-2q0fA:
undetectable
4p65C-2q0fA:
5.48
4p65D-2q0fA:
6.34
4p65J-2q0fA:
6.34
4p65L-2q0fA:
6.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2q0f RNA URIDYLYL
TRANSFERASE


(Trypanosoma
brucei)
PF03828
(PAP_assoc)
5 LEU A 245
HIS A 320
ALA A 324
LEU A 329
LEU A 177
None
1.13A 4p65C-2q0fA:
undetectable
4p65D-2q0fA:
undetectable
4p65J-2q0fA:
undetectable
4p65L-2q0fA:
undetectable
4p65C-2q0fA:
5.48
4p65D-2q0fA:
6.34
4p65J-2q0fA:
6.34
4p65L-2q0fA:
6.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2r1h HEMOGLOBIN SUBUNIT
ALPHA-4


(Oncorhynchus
mykiss)
PF00042
(Globin)
5 CYH A  70
LEU A  81
LEU A 133
ALA A 136
LEU A   2
None
1.05A 4p65C-2r1hA:
undetectable
4p65D-2r1hA:
undetectable
4p65J-2r1hA:
undetectable
4p65L-2r1hA:
undetectable
4p65C-2r1hA:
10.94
4p65D-2r1hA:
22.08
4p65J-2r1hA:
22.08
4p65L-2r1hA:
22.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2rg4 UNCHARACTERIZED
PROTEIN


(Oceanicola
granulosus)
PF13759
(2OG-FeII_Oxy_5)
5 LEU A  76
LEU A  19
VAL A  84
HIS A  83
LEU A 180
None
0.97A 4p65C-2rg4A:
undetectable
4p65D-2rg4A:
undetectable
4p65J-2rg4A:
undetectable
4p65L-2rg4A:
undetectable
4p65C-2rg4A:
7.57
4p65D-2rg4A:
10.98
4p65J-2rg4A:
10.98
4p65L-2rg4A:
10.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2voy CATION-TRANSPORTING
ATPASE


(Archaeoglobus
fulgidus)
PF00702
(Hydrolase)
5 LEU I 429
LEU I 655
ALA I 554
LEU I 586
VAL I 421
None
1.12A 4p65C-2voyI:
undetectable
4p65D-2voyI:
undetectable
4p65J-2voyI:
undetectable
4p65L-2voyI:
undetectable
4p65C-2voyI:
9.89
4p65D-2voyI:
15.15
4p65J-2voyI:
15.15
4p65L-2voyI:
15.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2voy CATION-TRANSPORTING
ATPASE


(Archaeoglobus
fulgidus)
PF00702
(Hydrolase)
5 LEU I 655
ALA I 554
LEU I 586
VAL I 421
LEU I 561
None
0.96A 4p65C-2voyI:
undetectable
4p65D-2voyI:
undetectable
4p65J-2voyI:
undetectable
4p65L-2voyI:
undetectable
4p65C-2voyI:
9.89
4p65D-2voyI:
15.15
4p65J-2voyI:
15.15
4p65L-2voyI:
15.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2x8u SERINE
PALMITOYLTRANSFERASE


(Sphingomonas
wittichii)
PF00155
(Aminotran_1_2)
5 LEU A 373
HIS A 310
LEU A 309
VAL A 332
LEU A 320
None
1.05A 4p65C-2x8uA:
undetectable
4p65D-2x8uA:
undetectable
4p65J-2x8uA:
undetectable
4p65L-2x8uA:
undetectable
4p65C-2x8uA:
12.04
4p65D-2x8uA:
6.76
4p65J-2x8uA:
6.76
4p65L-2x8uA:
6.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2yzm D-ALANINE--D-ALANINE
LIGASE


(Thermus
thermophilus)
PF01820
(Dala_Dala_lig_N)
PF07478
(Dala_Dala_lig_C)
5 LEU A  69
ALA A  35
LEU A   4
VAL A  91
LEU A  81
None
1.16A 4p65C-2yzmA:
undetectable
4p65D-2yzmA:
undetectable
4p65J-2yzmA:
undetectable
4p65L-2yzmA:
undetectable
4p65C-2yzmA:
4.38
4p65D-2yzmA:
7.21
4p65J-2yzmA:
7.21
4p65L-2yzmA:
7.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3bvc UNCHARACTERIZED
PROTEIN ISM_01780


(Roseovarius
nubinhibens)
PF13759
(2OG-FeII_Oxy_5)
5 LEU A  76
LEU A  19
VAL A  84
HIS A  83
LEU A 180
None
1.03A 4p65C-3bvcA:
undetectable
4p65D-3bvcA:
undetectable
4p65J-3bvcA:
undetectable
4p65L-3bvcA:
undetectable
4p65C-3bvcA:
7.57
4p65D-3bvcA:
10.24
4p65J-3bvcA:
10.24
4p65L-3bvcA:
10.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3cit SENSOR HISTIDINE
KINASE


(Pseudomonas
syringae group
genomosp. 3)
no annotation 5 LEU A 131
LEU A  51
ALA A  54
LEU A 148
LEU A 155
None
0.92A 4p65C-3citA:
undetectable
4p65D-3citA:
undetectable
4p65J-3citA:
undetectable
4p65L-3citA:
undetectable
4p65C-3citA:
11.90
4p65D-3citA:
14.41
4p65J-3citA:
14.41
4p65L-3citA:
14.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3e7w D-ALANINE--POLY(PHOS
PHORIBITOL) LIGASE
SUBUNIT 1


(Bacillus
subtilis)
PF00501
(AMP-binding)
PF13193
(AMP-binding_C)
5 LEU A 206
CYH A 214
LEU A 212
ALA A  19
LEU A  32
None
1.08A 4p65C-3e7wA:
undetectable
4p65D-3e7wA:
undetectable
4p65J-3e7wA:
undetectable
4p65L-3e7wA:
undetectable
4p65C-3e7wA:
3.91
4p65D-3e7wA:
7.97
4p65J-3e7wA:
7.97
4p65L-3e7wA:
7.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ef1 RNA POLYMERASE II
SUBUNIT A C-TERMINAL
DOMAIN PHOSPHATASE


(Schizosaccharomyces
pombe)
PF03031
(NIF)
PF12738
(PTCB-BRCT)
5 LEU A 491
LEU A 496
ALA A 517
LEU A 566
VAL A 557
None
1.10A 4p65C-3ef1A:
undetectable
4p65D-3ef1A:
undetectable
4p65J-3ef1A:
undetectable
4p65L-3ef1A:
undetectable
4p65C-3ef1A:
6.28
4p65D-3ef1A:
4.56
4p65J-3ef1A:
4.56
4p65L-3ef1A:
4.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3g8m SERINE
HYDROXYMETHYLTRANSFE
RASE


(Escherichia
coli)
PF00464
(SHMT)
5 LEU A 390
LEU A 337
ALA A 333
LEU A 323
VAL A 364
None
1.02A 4p65C-3g8mA:
undetectable
4p65D-3g8mA:
undetectable
4p65J-3g8mA:
undetectable
4p65L-3g8mA:
undetectable
4p65C-3g8mA:
4.90
4p65D-3g8mA:
6.49
4p65J-3g8mA:
6.49
4p65L-3g8mA:
6.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gdj HEMOGLOBIN SUBUNIT
BETA


(Camelus
dromedarius)
PF00042
(Globin)
5 LEU B 126
HIS B  12
LEU B  14
ALA B  10
LEU B  75
None
1.14A 4p65C-3gdjB:
undetectable
4p65D-3gdjB:
undetectable
4p65J-3gdjB:
undetectable
4p65L-3gdjB:
undetectable
4p65C-3gdjB:
5.63
4p65D-3gdjB:
12.26
4p65J-3gdjB:
12.26
4p65L-3gdjB:
12.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hhr HUMAN GROWTH HORMONE

(Homo sapiens)
PF00103
(Hormone_1)
5 LEU A 117
HIS A  21
LEU A  20
ALA A  17
LEU A 177
None
1.12A 4p65C-3hhrA:
undetectable
4p65D-3hhrA:
undetectable
4p65J-3hhrA:
undetectable
4p65L-3hhrA:
undetectable
4p65C-3hhrA:
7.89
4p65D-3hhrA:
10.29
4p65J-3hhrA:
10.29
4p65L-3hhrA:
10.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3i9v NADH-QUINONE
OXIDOREDUCTASE
SUBUNIT 3


(Thermus
thermophilus)
PF00384
(Molybdopterin)
PF01568
(Molydop_binding)
PF04879
(Molybdop_Fe4S4)
PF10588
(NADH-G_4Fe-4S_3)
PF13510
(Fer2_4)
5 LEU 3 641
LEU 3 360
ALA 3 357
LEU 3 345
VAL 3 341
None
1.09A 4p65C-3i9v3:
undetectable
4p65D-3i9v3:
undetectable
4p65J-3i9v3:
undetectable
4p65L-3i9v3:
undetectable
4p65C-3i9v3:
2.44
4p65D-3i9v3:
3.60
4p65J-3i9v3:
3.60
4p65L-3i9v3:
3.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3igh UNCHARACTERIZED
METAL-DEPENDENT
HYDROLASE


(Pyrococcus
horikoshii)
PF07969
(Amidohydro_3)
5 LEU X 285
ALA X 290
LEU X 292
VAL X 359
LEU X 337
None
1.13A 4p65C-3ighX:
undetectable
4p65D-3ighX:
undetectable
4p65J-3ighX:
undetectable
4p65L-3ighX:
undetectable
4p65C-3ighX:
4.64
4p65D-3ighX:
6.05
4p65J-3ighX:
6.05
4p65L-3ighX:
6.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mdy BONE MORPHOGENETIC
PROTEIN RECEPTOR
TYPE-1B


(Homo sapiens)
PF07714
(Pkinase_Tyr)
PF08515
(TGF_beta_GS)
5 LEU A 491
LEU A 302
ALA A 305
LEU A 407
LEU A 463
None
1.07A 4p65C-3mdyA:
undetectable
4p65D-3mdyA:
undetectable
4p65J-3mdyA:
undetectable
4p65L-3mdyA:
undetectable
4p65C-3mdyA:
5.65
4p65D-3mdyA:
5.97
4p65J-3mdyA:
5.97
4p65L-3mdyA:
5.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ngw MOLYBDOPTERIN-GUANIN
E DINUCLEOTIDE
BIOSYNTHESIS PROTEIN
A (MOBA)


(Archaeoglobus
fulgidus)
PF12804
(NTP_transf_3)
5 LEU A 138
CYH A  86
LEU A  80
ALA A 134
VAL A  88
None
1.16A 4p65C-3ngwA:
undetectable
4p65D-3ngwA:
undetectable
4p65J-3ngwA:
undetectable
4p65L-3ngwA:
undetectable
4p65C-3ngwA:
16.13
4p65D-3ngwA:
12.90
4p65J-3ngwA:
12.90
4p65L-3ngwA:
12.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3no3 GLYCEROPHOSPHODIESTE
R PHOSPHODIESTERASE


(Parabacteroides
distasonis)
PF03009
(GDPD)
5 LEU A 120
LEU A 109
ALA A 112
LEU A  47
VAL A  62
None
1.06A 4p65C-3no3A:
undetectable
4p65D-3no3A:
undetectable
4p65J-3no3A:
undetectable
4p65L-3no3A:
undetectable
4p65C-3no3A:
8.18
4p65D-3no3A:
7.98
4p65J-3no3A:
7.98
4p65L-3no3A:
7.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3og9 PROTEIN YAHD A
COPPER INDUCIBLE
HYDROLASE


(Lactococcus
lactis)
PF01738
(DLH)
5 LEU A 114
HIS A 131
ALA A 129
LEU A 151
VAL A 160
None
1.07A 4p65C-3og9A:
undetectable
4p65D-3og9A:
undetectable
4p65J-3og9A:
undetectable
4p65L-3og9A:
undetectable
4p65C-3og9A:
5.77
4p65D-3og9A:
9.60
4p65J-3og9A:
9.60
4p65L-3og9A:
9.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3p0w MANDELATE
RACEMASE/MUCONATE
LACTONIZING PROTEIN


(Ralstonia
pickettii)
PF13378
(MR_MLE_C)
5 LEU A 136
ALA A 135
LEU A  43
VAL A  68
LEU A  65
None
1.15A 4p65C-3p0wA:
undetectable
4p65D-3p0wA:
undetectable
4p65J-3p0wA:
undetectable
4p65L-3p0wA:
undetectable
4p65C-3p0wA:
4.03
4p65D-3p0wA:
11.32
4p65J-3p0wA:
11.32
4p65L-3p0wA:
11.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3pdi NITROGENASE MOFE
COFACTOR
BIOSYNTHESIS PROTEIN
NIFN


(Azotobacter
vinelandii)
PF00148
(Oxidored_nitro)
5 LEU B 332
ALA B 314
LEU B 431
VAL B 423
LEU B 424
None
0.91A 4p65C-3pdiB:
undetectable
4p65D-3pdiB:
undetectable
4p65J-3pdiB:
undetectable
4p65L-3pdiB:
undetectable
4p65C-3pdiB:
7.61
4p65D-3pdiB:
6.50
4p65J-3pdiB:
6.50
4p65L-3pdiB:
6.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3sdi PROTEASOME COMPONENT
PRE5


(Saccharomyces
cerevisiae)
PF00227
(Proteasome)
PF10584
(Proteasome_A_N)
5 CYH E  70
LEU E  92
ALA E 112
LEU E 107
HIS E  73
None
0.94A 4p65C-3sdiE:
undetectable
4p65D-3sdiE:
undetectable
4p65J-3sdiE:
undetectable
4p65L-3sdiE:
undetectable
4p65C-3sdiE:
13.95
4p65D-3sdiE:
9.91
4p65J-3sdiE:
9.91
4p65L-3sdiE:
9.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3slk POLYKETIDE SYNTHASE
EXTENDER MODULE 2


(Saccharopolyspora
spinosa)
PF08240
(ADH_N)
PF08659
(KR)
PF13602
(ADH_zinc_N_2)
5 LEU A  13
ALA A 149
LEU A 163
VAL A 136
LEU A  97
None
1.07A 4p65C-3slkA:
undetectable
4p65D-3slkA:
undetectable
4p65J-3slkA:
undetectable
4p65L-3slkA:
undetectable
4p65C-3slkA:
2.26
4p65D-3slkA:
3.66
4p65J-3slkA:
3.66
4p65L-3slkA:
3.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3tz6 ASPARTATE-SEMIALDEHY
DE DEHYDROGENASE


(Mycobacterium
tuberculosis)
PF01118
(Semialdhyde_dh)
PF02774
(Semialdhyde_dhC)
5 LEU A 142
LEU A 277
ALA A 273
LEU A 317
VAL A 321
None
1.02A 4p65C-3tz6A:
undetectable
4p65D-3tz6A:
undetectable
4p65J-3tz6A:
undetectable
4p65L-3tz6A:
undetectable
4p65C-3tz6A:
6.54
4p65D-3tz6A:
7.47
4p65J-3tz6A:
7.47
4p65L-3tz6A:
7.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3uet ALPHA-1,3/4-FUCOSIDA
SE


(Bifidobacterium
longum)
PF01120
(Alpha_L_fucos)
5 LEU A 373
ALA A 473
LEU A 395
VAL A 461
LEU A 421
None
1.10A 4p65C-3uetA:
undetectable
4p65D-3uetA:
undetectable
4p65J-3uetA:
undetectable
4p65L-3uetA:
undetectable
4p65C-3uetA:
4.32
4p65D-3uetA:
4.06
4p65J-3uetA:
4.06
4p65L-3uetA:
4.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3wqf D-THREO-3-HYDROXYASP
ARTATE DEHYDRATASE


(Delftia sp.
HT23)
PF01168
(Ala_racemase_N)
PF14031
(D-ser_dehydrat)
5 LEU A  67
CYH A 103
LEU A  98
ALA A  95
LEU A 107
None
1.10A 4p65C-3wqfA:
undetectable
4p65D-3wqfA:
undetectable
4p65J-3wqfA:
undetectable
4p65L-3wqfA:
undetectable
4p65C-3wqfA:
3.85
4p65D-3wqfA:
7.69
4p65J-3wqfA:
7.69
4p65L-3wqfA:
7.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4dkb DEOXYURIDINE
TRIPHOSPHATASE


(Trypanosoma
brucei)
PF08761
(dUTPase_2)
6 LEU A 238
HIS A 209
LEU A 211
ALA A 207
HIS A  82
LEU A  24
None
None
None
None
DUN  A 303 (-3.7A)
DUN  A 303 (-4.3A)
1.40A 4p65C-4dkbA:
undetectable
4p65D-4dkbA:
undetectable
4p65J-4dkbA:
undetectable
4p65L-4dkbA:
undetectable
4p65C-4dkbA:
5.04
4p65D-4dkbA:
7.53
4p65J-4dkbA:
7.53
4p65L-4dkbA:
7.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4g3a CLIP-ASSOCIATING
PROTEIN


(Drosophila
melanogaster)
PF12348
(CLASP_N)
5 LEU A  31
LEU A  35
ALA A  72
LEU A  54
LEU A  80
None
1.10A 4p65C-4g3aA:
undetectable
4p65D-4g3aA:
undetectable
4p65J-4g3aA:
undetectable
4p65L-4g3aA:
undetectable
4p65C-4g3aA:
7.98
4p65D-4g3aA:
9.27
4p65J-4g3aA:
9.27
4p65L-4g3aA:
9.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4g8z DIHYDROFOLATE
REDUCTASE


(Pneumocystis
jirovecii)
PF00186
(DHFR_1)
5 LEU X  98
LEU X   7
ALA X 132
LEU X 128
VAL X  54
None
None
None
NDP  X 302 (-4.0A)
None
1.15A 4p65C-4g8zX:
undetectable
4p65D-4g8zX:
undetectable
4p65J-4g8zX:
undetectable
4p65L-4g8zX:
undetectable
4p65C-4g8zX:
7.41
4p65D-4g8zX:
10.30
4p65J-4g8zX:
10.30
4p65L-4g8zX:
10.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4h05 AMINOGLYCOSIDE-O-PHO
SPHOTRANSFERASE VIII


(Streptomyces
rimosus)
PF01636
(APH)
5 LEU A 202
LEU A  62
LEU A 113
VAL A 180
LEU A 120
None
1.14A 4p65C-4h05A:
undetectable
4p65D-4h05A:
undetectable
4p65J-4h05A:
undetectable
4p65L-4h05A:
undetectable
4p65C-4h05A:
4.95
4p65D-4h05A:
8.44
4p65J-4h05A:
8.44
4p65L-4h05A:
8.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ivn TRANSCRIPTIONAL
REGULATOR


(Vibrio
vulnificus)
PF01380
(SIS)
PF01418
(HTH_6)
5 LEU A   8
LEU A  30
ALA A  33
LEU A  74
LEU A  58
None
1.14A 4p65C-4ivnA:
undetectable
4p65D-4ivnA:
undetectable
4p65J-4ivnA:
undetectable
4p65L-4ivnA:
undetectable
4p65C-4ivnA:
5.78
4p65D-4ivnA:
8.05
4p65J-4ivnA:
8.05
4p65L-4ivnA:
8.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4kng E3 UBIQUITIN-PROTEIN
LIGASE RNF43


(Homo sapiens)
no annotation 5 LEU E 122
LEU E 151
ALA E 147
LEU E 109
VAL E 137
None
1.16A 4p65C-4kngE:
undetectable
4p65D-4kngE:
undetectable
4p65J-4kngE:
undetectable
4p65L-4kngE:
undetectable
4p65C-4kngE:
10.14
4p65D-4kngE:
11.25
4p65J-4kngE:
11.25
4p65L-4kngE:
11.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4m5d RIBOSOMAL
RNA-PROCESSING
PROTEIN 7


(Saccharomyces
cerevisiae)
PF12923
(RRP7)
5 LEU B  55
CYH B 137
ALA B  39
VAL B  71
LEU B  74
None
1.16A 4p65C-4m5dB:
undetectable
4p65D-4m5dB:
undetectable
4p65J-4m5dB:
undetectable
4p65L-4m5dB:
undetectable
4p65C-4m5dB:
5.41
4p65D-4m5dB:
8.73
4p65J-4m5dB:
8.73
4p65L-4m5dB:
8.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4mni TRAP DICARBOXYLATE
TRANSPORTER-DCTP
SUBUNIT


(Polaromonas sp.
JS666)
PF03480
(DctP)
5 LEU A 235
LEU A  34
LEU A 260
VAL A  45
LEU A  49
None
1.11A 4p65C-4mniA:
undetectable
4p65D-4mniA:
undetectable
4p65J-4mniA:
undetectable
4p65L-4mniA:
undetectable
4p65C-4mniA:
6.49
4p65D-4mniA:
5.69
4p65J-4mniA:
5.69
4p65L-4mniA:
5.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4n6f PUTATIVE THIOSUGAR
SYNTHASE


(Amycolatopsis
orientalis)
PF05690
(ThiG)
5 LEU A 132
LEU A  94
ALA A  97
LEU A 109
VAL A 113
None
1.09A 4p65C-4n6fA:
undetectable
4p65D-4n6fA:
undetectable
4p65J-4n6fA:
undetectable
4p65L-4n6fA:
undetectable
4p65C-4n6fA:
4.58
4p65D-4n6fA:
7.03
4p65J-4n6fA:
7.03
4p65L-4n6fA:
7.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4nph PROBABLE SECRETION
SYSTEM APPARATUS ATP
SYNTHASE SSAN


(Salmonella
enterica)
PF00006
(ATP-synt_ab)
5 LEU A 230
LEU A 254
ALA A 251
LEU A 249
LEU A 325
None
0.86A 4p65C-4nphA:
undetectable
4p65D-4nphA:
undetectable
4p65J-4nphA:
undetectable
4p65L-4nphA:
undetectable
4p65C-4nphA:
5.99
4p65D-4nphA:
8.98
4p65J-4nphA:
8.98
4p65L-4nphA:
8.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4o89 RNA 3'-TERMINAL
PHOSPHATE CYCLASE


(Pyrococcus
horikoshii)
PF01137
(RTC)
PF05189
(RTC_insert)
5 CYH A 279
LEU A 245
ALA A 139
LEU A 284
LEU A 292
None
1.12A 4p65C-4o89A:
undetectable
4p65D-4o89A:
undetectable
4p65J-4o89A:
undetectable
4p65L-4o89A:
undetectable
4p65C-4o89A:
8.28
4p65D-4o89A:
7.54
4p65J-4o89A:
7.54
4p65L-4o89A:
7.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ppz SUCCINYL-DIAMINOPIME
LATE DESUCCINYLASE


(Neisseria
meningitidis)
PF01546
(Peptidase_M20)
PF07687
(M20_dimer)
5 LEU A 216
LEU A 213
ALA A 212
LEU A 277
LEU A 252
None
0.95A 4p65C-4ppzA:
undetectable
4p65D-4ppzA:
undetectable
4p65J-4ppzA:
undetectable
4p65L-4ppzA:
undetectable
4p65C-4ppzA:
4.92
4p65D-4ppzA:
7.89
4p65J-4ppzA:
7.89
4p65L-4ppzA:
7.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4rld ASPARTIC PROTEASE
BLA G 2


(Blattella
germanica)
PF00026
(Asp)
5 LEU A 107
ALA A  49
LEU A  53
VAL A  30
LEU A 115
None
1.03A 4p65C-4rldA:
undetectable
4p65D-4rldA:
undetectable
4p65J-4rldA:
undetectable
4p65L-4rldA:
undetectable
4p65C-4rldA:
5.36
4p65D-4rldA:
9.95
4p65J-4rldA:
9.95
4p65L-4rldA:
9.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4rlv ANKYRIN-1, ANKYRIN-2

(Homo sapiens;
Mus musculus)
PF00023
(Ank)
PF12796
(Ank_2)
PF13637
(Ank_4)
PF13857
(Ank_5)
5 CYH A2375
ALA A2368
LEU A2384
VAL A2413
LEU A2417
None
1.16A 4p65C-4rlvA:
undetectable
4p65D-4rlvA:
undetectable
4p65J-4rlvA:
undetectable
4p65L-4rlvA:
undetectable
4p65C-4rlvA:
5.32
4p65D-4rlvA:
4.73
4p65J-4rlvA:
4.73
4p65L-4rlvA:
4.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4rlv ANKYRIN-1, ANKYRIN-2

(Homo sapiens;
Mus musculus)
PF00023
(Ank)
PF12796
(Ank_2)
PF13637
(Ank_4)
PF13857
(Ank_5)
5 LEU A2171
ALA A2195
LEU A2211
VAL A2248
LEU A2252
None
1.14A 4p65C-4rlvA:
undetectable
4p65D-4rlvA:
undetectable
4p65J-4rlvA:
undetectable
4p65L-4rlvA:
undetectable
4p65C-4rlvA:
5.32
4p65D-4rlvA:
4.73
4p65J-4rlvA:
4.73
4p65L-4rlvA:
4.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wj7 MALCAVERNIN

(Homo sapiens)
no annotation 5 LEU A  70
HIS A 151
LEU A 152
ALA A 199
LEU A 105
None
1.16A 4p65C-4wj7A:
undetectable
4p65D-4wj7A:
undetectable
4p65J-4wj7A:
undetectable
4p65L-4wj7A:
undetectable
4p65C-4wj7A:
6.75
4p65D-4wj7A:
14.07
4p65J-4wj7A:
14.07
4p65L-4wj7A:
14.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wja UNCHARACTERIZED
PROTEIN C9ORF142


(Homo sapiens)
PF15384
(PAXX)
5 CYH A  22
LEU A  87
ALA A  94
LEU A  89
LEU A  47
None
1.04A 4p65C-4wjaA:
undetectable
4p65D-4wjaA:
undetectable
4p65J-4wjaA:
undetectable
4p65L-4wjaA:
undetectable
4p65C-4wjaA:
11.46
4p65D-4wjaA:
11.18
4p65J-4wjaA:
11.18
4p65L-4wjaA:
11.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wjl INACTIVE DIPEPTIDYL
PEPTIDASE 10


(Homo sapiens)
PF00326
(Peptidase_S9)
PF00930
(DPPIV_N)
5 HIS A 741
LEU A 742
ALA A 745
VAL A 707
LEU A 708
None
0.74A 4p65C-4wjlA:
undetectable
4p65D-4wjlA:
undetectable
4p65J-4wjlA:
undetectable
4p65L-4wjlA:
undetectable
4p65C-4wjlA:
2.79
4p65D-4wjlA:
3.60
4p65J-4wjlA:
3.60
4p65L-4wjlA:
3.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xef PROTEIN-TYROSINE
KINASE 2-BETA
20-MER PEPTIDE
CONTAINING LD1 MOTIF
OF LEUPAXIN


(Homo sapiens;
Homo sapiens)
PF03623
(Focal_AT)
no annotation
5 LEU A 953
HIS A 981
LEU A 983
ALA A 979
LEU B  11
None
1.07A 4p65C-4xefA:
undetectable
4p65D-4xefA:
undetectable
4p65J-4xefA:
undetectable
4p65L-4xefA:
undetectable
4p65C-4xefA:
6.47
4p65D-4xefA:
8.63
4p65J-4xefA:
8.63
4p65L-4xefA:
8.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xev FUSION PROTEIN OF
PROTEIN-TYROSINE
KINASE 2-BETA FAT
DOMAIN AND LEUPAXIN
LD1 MOTIF


(Homo sapiens)
PF03623
(Focal_AT)
5 LEU A 953
HIS A 981
LEU A 983
ALA A 979
LEU A2011
None
1.14A 4p65C-4xevA:
undetectable
4p65D-4xevA:
undetectable
4p65J-4xevA:
undetectable
4p65L-4xevA:
undetectable
4p65C-4xevA:
9.28
4p65D-4xevA:
9.26
4p65J-4xevA:
9.26
4p65L-4xevA:
9.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xpz RNA POLYMERASE II
SUBUNIT A C-TERMINAL
DOMAIN PHOSPHATASE


(Schizosaccharomyces
pombe)
PF03031
(NIF)
PF12738
(PTCB-BRCT)
5 LEU A 429
LEU A 434
ALA A 455
LEU A 504
VAL A 495
None
1.13A 4p65C-4xpzA:
undetectable
4p65D-4xpzA:
undetectable
4p65J-4xpzA:
undetectable
4p65L-4xpzA:
undetectable
4p65C-4xpzA:
4.35
4p65D-4xpzA:
5.85
4p65J-4xpzA:
5.85
4p65L-4xpzA:
5.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4yii UBIQUITIN-CONJUGATIN
G ENZYME E2 C


(Homo sapiens)
PF00179
(UQ_con)
5 LEU U 132
LEU U  83
ALA U  52
LEU U  42
LEU U  35
None
1.02A 4p65C-4yiiU:
undetectable
4p65D-4yiiU:
undetectable
4p65J-4yiiU:
undetectable
4p65L-4yiiU:
undetectable
4p65C-4yiiU:
8.06
4p65D-4yiiU:
11.03
4p65J-4yiiU:
11.03
4p65L-4yiiU:
11.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ysw XANTHINE
DEHYDROGENASE/OXIDAS
E


(Rattus
norvegicus)
PF00111
(Fer2)
PF00941
(FAD_binding_5)
PF01315
(Ald_Xan_dh_C)
PF01799
(Fer2_2)
PF02738
(Ald_Xan_dh_C2)
PF03450
(CO_deh_flav_C)
5 HIS A 817
ALA A 815
LEU A 635
VAL A 776
LEU A 780
None
1.11A 4p65C-4yswA:
undetectable
4p65D-4yswA:
undetectable
4p65J-4yswA:
undetectable
4p65L-4yswA:
undetectable
4p65C-4yswA:
1.48
4p65D-4yswA:
2.17
4p65J-4yswA:
2.17
4p65L-4yswA:
2.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4yu5 IMMUNE INHIBITOR A,
METALLOPROTEASE


(Bacillus cereus)
PF05547
(Peptidase_M6)
5 LEU A 169
HIS A 275
LEU A 274
ALA A 277
LEU A 241
None
1.13A 4p65C-4yu5A:
undetectable
4p65D-4yu5A:
undetectable
4p65J-4yu5A:
undetectable
4p65L-4yu5A:
undetectable
4p65C-4yu5A:
2.58
4p65D-4yu5A:
3.94
4p65J-4yu5A:
3.94
4p65L-4yu5A:
3.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5a46 FIBROBLAST GROWTH
FACTOR RECEPTOR 1
(FMS-RELATED
TYROSINE KINASE 2,
PFEIFFER SYNDROME),
ISOFORM CRA_B


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 CYH A 603
LEU A 569
LEU A 573
ALA A 626
LEU A 689
None
1.16A 4p65C-5a46A:
undetectable
4p65D-5a46A:
undetectable
4p65J-5a46A:
undetectable
4p65L-5a46A:
undetectable
4p65C-5a46A:
3.95
4p65D-5a46A:
6.77
4p65J-5a46A:
6.77
4p65L-5a46A:
6.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5cb2 PROTEIN SEY1

(Candida
albicans)
PF05879
(RHD3)
5 LEU A 273
LEU A  78
VAL A 202
HIS A 250
LEU A 252
None
1.09A 4p65C-5cb2A:
undetectable
4p65D-5cb2A:
undetectable
4p65J-5cb2A:
undetectable
4p65L-5cb2A:
undetectable
4p65C-5cb2A:
4.32
4p65D-5cb2A:
4.01
4p65J-5cb2A:
4.01
4p65L-5cb2A:
4.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ce5 TRIACYLGLYCEROL
LIPASE


(Geobacillus
thermocatenulatus)
no annotation 5 LEU A  71
LEU A 123
ALA A  67
LEU A  52
VAL A 159
None
1.10A 4p65C-5ce5A:
undetectable
4p65D-5ce5A:
undetectable
4p65J-5ce5A:
undetectable
4p65L-5ce5A:
undetectable
4p65C-5ce5A:
4.31
4p65D-5ce5A:
7.23
4p65J-5ce5A:
7.23
4p65L-5ce5A:
7.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ckm MANNAN-BINDING
LECTIN SERINE
PEPTIDASE 2


(Rattus
norvegicus)
PF00431
(CUB)
PF07645
(EGF_CA)
5 LEU A  94
LEU A  40
LEU A  67
VAL A  58
LEU A  70
None
1.03A 4p65C-5ckmA:
undetectable
4p65D-5ckmA:
undetectable
4p65J-5ckmA:
undetectable
4p65L-5ckmA:
undetectable
4p65C-5ckmA:
6.28
4p65D-5ckmA:
6.27
4p65J-5ckmA:
6.27
4p65L-5ckmA:
6.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5cof UNCHARACTERIZED
PROTEIN


(Escherichia
coli)
PF08020
(DUF1706)
5 LEU A 160
ALA A 156
LEU A  52
VAL A 108
LEU A 111
None
1.12A 4p65C-5cofA:
undetectable
4p65D-5cofA:
undetectable
4p65J-5cofA:
undetectable
4p65L-5cofA:
undetectable
4p65C-5cofA:
7.69
4p65D-5cofA:
12.77
4p65J-5cofA:
12.77
4p65L-5cofA:
12.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5czz CRISPR-ASSOCIATED
ENDONUCLEASE CAS9


(Staphylococcus
aureus)
PF13395
(HNH_4)
PF16592
(Cas9_REC)
5 LEU A 183
LEU A 109
LEU A 100
HIS A 191
LEU A  76
None
1.11A 4p65C-5czzA:
undetectable
4p65D-5czzA:
undetectable
4p65J-5czzA:
undetectable
4p65L-5czzA:
undetectable
4p65C-5czzA:
2.01
4p65D-5czzA:
4.05
4p65J-5czzA:
4.05
4p65L-5czzA:
4.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5gvi UBIQUITIN
CARBOXYL-TERMINAL
HYDROLASE 30


(Danio rerio)
PF00443
(UCH)
5 LEU A 119
LEU A 139
ALA A 136
LEU A  66
LEU A 161
None
1.14A 4p65C-5gviA:
undetectable
4p65D-5gviA:
undetectable
4p65J-5gviA:
undetectable
4p65L-5gviA:
undetectable
4p65C-5gviA:
5.17
4p65D-5gviA:
5.74
4p65J-5gviA:
5.74
4p65L-5gviA:
5.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5hjr NEUTRAL
ALPHA-GLUCOSIDASE AB


(Mus musculus)
PF01055
(Glyco_hydro_31)
PF13802
(Gal_mutarotas_2)
5 HIS A 477
LEU A 475
ALA A 479
VAL A 431
LEU A 432
None
1.04A 4p65C-5hjrA:
undetectable
4p65D-5hjrA:
undetectable
4p65J-5hjrA:
undetectable
4p65L-5hjrA:
undetectable
4p65C-5hjrA:
2.59
4p65D-5hjrA:
3.31
4p65J-5hjrA:
3.31
4p65L-5hjrA:
3.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ja1 ENTEROBACTIN
SYNTHASE COMPONENT F


(Escherichia
coli)
PF00501
(AMP-binding)
PF00550
(PP-binding)
PF00668
(Condensation)
PF00975
(Thioesterase)
PF13193
(AMP-binding_C)
5 LEU A1139
LEU A1224
ALA A1220
VAL A1186
LEU A1187
None
1.09A 4p65C-5ja1A:
undetectable
4p65D-5ja1A:
undetectable
4p65J-5ja1A:
undetectable
4p65L-5ja1A:
undetectable
4p65C-5ja1A:
1.55
4p65D-5ja1A:
2.38
4p65J-5ja1A:
2.38
4p65L-5ja1A:
2.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5jpe SERINE/THREONINE-PRO
TEIN PHOSPHATASE


(Candida
albicans)
PF00149
(Metallophos)
PF16891
(STPPase_N)
5 CYH A 456
CYH A 336
ALA A 331
VAL A 226
LEU A 253
None
1.15A 4p65C-5jpeA:
undetectable
4p65D-5jpeA:
undetectable
4p65J-5jpeA:
undetectable
4p65L-5jpeA:
undetectable
4p65C-5jpeA:
6.16
4p65D-5jpeA:
7.75
4p65J-5jpeA:
7.75
4p65L-5jpeA:
7.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5k7f TRANSCRIPTIONAL
REGULATOR, TETR
FAMILY


(Myxococcus
xanthus)
PF00440
(TetR_N)
5 LEU A  90
LEU A 138
ALA A 141
VAL A  76
LEU A  77
None
0.88A 4p65C-5k7fA:
undetectable
4p65D-5k7fA:
undetectable
4p65J-5k7fA:
undetectable
4p65L-5k7fA:
undetectable
4p65C-5k7fA:
14.00
4p65D-5k7fA:
9.38
4p65J-5k7fA:
9.38
4p65L-5k7fA:
9.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ool 39S RIBOSOMAL
PROTEIN L37,
MITOCHONDRIAL


(Homo sapiens)
PF07147
(PDCD9)
5 LEU 5 198
HIS 5 420
LEU 5 419
ALA 5 422
HIS 5 289
None
1.05A 4p65C-5ool5:
undetectable
4p65D-5ool5:
undetectable
4p65J-5ool5:
undetectable
4p65L-5ool5:
undetectable
4p65C-5ool5:
4.70
4p65D-5ool5:
6.42
4p65J-5ool5:
6.42
4p65L-5ool5:
6.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5t8y EPOXYQUEUOSINE
REDUCTASE


(Bacillus
subtilis)
PF08331
(DUF1730)
PF13484
(Fer4_16)
PF13646
(HEAT_2)
5 CYH A 156
LEU A 209
CYH A 194
LEU A 203
ALA A 202
B12  A 503 ( 4.5A)
B12  A 503 ( 3.9A)
SF4  A 501 (-2.2A)
SF4  A 502 ( 4.6A)
SF4  A 502 ( 3.9A)
1.06A 4p65C-5t8yA:
undetectable
4p65D-5t8yA:
undetectable
4p65J-5t8yA:
undetectable
4p65L-5t8yA:
undetectable
4p65C-5t8yA:
3.62
4p65D-5t8yA:
5.66
4p65J-5t8yA:
5.66
4p65L-5t8yA:
5.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5u4z REPRESSOR OF RNA
POLYMERASE III
TRANSCRIPTION


(Citrus sinensis)
PF09174
(Maf1)
5 LEU A 145
LEU A 141
ALA A 144
LEU A   9
LEU A  16
None
1.08A 4p65C-5u4zA:
undetectable
4p65D-5u4zA:
undetectable
4p65J-5u4zA:
undetectable
4p65L-5u4zA:
undetectable
4p65C-5u4zA:
5.70
4p65D-5u4zA:
7.94
4p65J-5u4zA:
7.94
4p65L-5u4zA:
7.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ux2 ALDEHYDE
DECARBONYLASE


(Synechococcus
sp. RS9917)
no annotation 5 CYH A 110
LEU A 106
HIS A 141
LEU A 142
ALA A 145
None
None
FE  A 301 (-3.5A)
None
None
1.13A 4p65C-5ux2A:
undetectable
4p65D-5ux2A:
undetectable
4p65J-5ux2A:
undetectable
4p65L-5ux2A:
undetectable
4p65C-5ux2A:
undetectable
4p65D-5ux2A:
undetectable
4p65J-5ux2A:
undetectable
4p65L-5ux2A:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5uxb MACROLIDE
2'-PHOSPHOTRANSFERAS
E MPHH


(Brachybacterium
faecium)
PF01636
(APH)
5 LEU A 257
HIS A 230
LEU A 243
VAL A 127
LEU A 123
None
0.89A 4p65C-5uxbA:
undetectable
4p65D-5uxbA:
undetectable
4p65J-5uxbA:
undetectable
4p65L-5uxbA:
undetectable
4p65C-5uxbA:
8.55
4p65D-5uxbA:
8.64
4p65J-5uxbA:
8.64
4p65L-5uxbA:
8.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vfr PROTEASOME SUBUNIT
ALPHA TYPE-4


(Homo sapiens)
no annotation 5 LEU I  35
LEU I  44
ALA I  46
LEU I 197
LEU I 236
None
1.08A 4p65C-5vfrI:
undetectable
4p65D-5vfrI:
undetectable
4p65J-5vfrI:
undetectable
4p65L-5vfrI:
undetectable
4p65C-5vfrI:
undetectable
4p65D-5vfrI:
undetectable
4p65J-5vfrI:
undetectable
4p65L-5vfrI:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vpq BETA-LACTAMASE

(Paraburkholderia
phymatum)
PF13354
(Beta-lactamase2)
5 LEU A 182
LEU A  63
ALA A  66
LEU A 197
VAL A 237
None
1.11A 4p65C-5vpqA:
undetectable
4p65D-5vpqA:
undetectable
4p65J-5vpqA:
undetectable
4p65L-5vpqA:
undetectable
4p65C-5vpqA:
5.35
4p65D-5vpqA:
6.41
4p65J-5vpqA:
6.41
4p65L-5vpqA:
6.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5w19 TRYPTOPHANASE

(Proteus
vulgaris)
no annotation 5 LEU A 437
LEU A 380
ALA A 379
LEU A 444
VAL A 357
None
1.08A 4p65C-5w19A:
undetectable
4p65D-5w19A:
undetectable
4p65J-5w19A:
undetectable
4p65L-5w19A:
undetectable
4p65C-5w19A:
undetectable
4p65D-5w19A:
undetectable
4p65J-5w19A:
undetectable
4p65L-5w19A:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5y4d ANKYRIN-1,ANKYRIN-2,
ANKYRIN-2


(Homo sapiens;
Mus musculus)
PF00023
(Ank)
PF12796
(Ank_2)
PF13637
(Ank_4)
5 LEU A2171
ALA A2195
LEU A2211
VAL A2248
LEU A2252
None
1.12A 4p65C-5y4dA:
undetectable
4p65D-5y4dA:
undetectable
4p65J-5y4dA:
undetectable
4p65L-5y4dA:
undetectable
4p65C-5y4dA:
4.95
4p65D-5y4dA:
4.26
4p65J-5y4dA:
4.26
4p65L-5y4dA:
4.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6cn7 AEROBACTIN SYNTHASE
IUCC


(Klebsiella
pneumoniae)
no annotation 5 LEU A 548
LEU A  21
LEU A  78
VAL A  84
LEU A  41
None
1.11A 4p65C-6cn7A:
undetectable
4p65D-6cn7A:
undetectable
4p65J-6cn7A:
undetectable
4p65L-6cn7A:
undetectable
4p65C-6cn7A:
undetectable
4p65D-6cn7A:
undetectable
4p65J-6cn7A:
undetectable
4p65L-6cn7A:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6grw -

(-)
no annotation 5 LEU A 190
ALA A  98
LEU A  94
VAL A 147
HIS A 148
None
1.14A 4p65C-6grwA:
undetectable
4p65D-6grwA:
undetectable
4p65J-6grwA:
undetectable
4p65L-6grwA:
undetectable
4p65C-6grwA:
undetectable
4p65D-6grwA:
undetectable
4p65J-6grwA:
undetectable
4p65L-6grwA:
undetectable